U.S. markets closed

Globus Medical, Inc. (GMED)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
53.64+0.58 (+1.09%)
Al cierre: 04:00PM EDT
53.50 -0.14 (-0.26%)
Fuera de horario: 06:40PM EDT

Globus Medical, Inc.

2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800
https://www.globusmedical.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo5,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. David C. PaulCo-Founder & Executive Chairman1.09MN/D1967
Mr. Daniel T. ScavillaPresident, CEO & Director1.37MN/D1965
Mr. Keith W. PfeilCFO & COO675.89kN/D1980
Ms. Kelly G. Huller Esq.Senior VP, General Counsel & Secretary543.24k624.35k1972
Mr. Brian J. KearnsSenior Vice President of Business Development & Investor RelationsN/DN/D1967
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Gestión corporativa

La calificación ISS Governance QuickScore de Globus Medical, Inc. a partir del 1 de marzo de 2024 es 10. Las puntuaciones principales son Auditoría: 8; Junta: 10; Derechos del accionista: 10; Compensación: 7.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.